Browsing Tag
COVID-19
305 posts
Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for…
February 22, 2021
ADB grants $25m to Philippine govt for procuring COVID-19 vaccines
The Asian Development Bank (ADB) has sanctioned $25 million to help the government of the Philippines to buy…
February 21, 2021
Pfizer withdraws emergency use application for COVID-19 vaccine in India
US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in…
February 5, 2021
UAE grants emergency use authorization for Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) has announced that the UAE Ministry of Health and Prevention (MOHAP) has…
January 23, 2021
Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V Covid-19 vaccine
Dr. Reddy’s Laboratories has recently received approval from the Drugs Control General of India (DCGI) to proceed with…
January 16, 2021
Dr. Reddy’s reports success in Sputnik V phase 2 trial, paving the way for phase 3 in India
Dr. Reddy’s Laboratories has announced a major milestone in the development of Sputnik V, the Russian Covid-19 vaccine,…
January 14, 2021
India grants emergency approval to Covishield and Covaxin vaccines for Covid-19
In a significant development in the battle against Covid-19, the Drugs Controller General of India (DCGI) has granted…
January 3, 2021
India’s DCGI grants emergency approval to Covishield and Covaxin vaccines
In a major step forward in India’s fight against the Covid-19 pandemic, the Drugs Controller General of India…
January 3, 2021
Switzerland becomes first country to grant full approval to Pfizer-BioNTech Covid-19 vaccine
Switzerland becomes the first nation to fully approve the Pfizer-BioNTech Covid-19 vaccine. Find out how Swissmedic's rigorous process could influence global vaccine confidence.
December 20, 2020
Lilly begins real-world Covid-19 study of bamlanivimab in New Mexico to assess outcomes in high-risk patients
Eli Lilly begins a real-world Covid-19 study of bamlanivimab in New Mexico. Find out how mobile clinics aim to reduce hospitalizations in high-risk patients.
December 19, 2020